Philip Hobson

DEPUTY HEAD OF FLOW CYTOMETRY

Displaying 1 - 9 of 9
Last updated : 29 March 2023 02:40

Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study

Authors (89)
Nature Cancer
Published
Crick labs/ facilities
Full details

Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry

Authors (18)
Nature Communications
Published
Crick labs/ facilities
Full details

Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients

Authors (86)
The Lancet
Published
Crick labs/ facilities
Full details

AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC

Authors (24)
Lancet
Published
Crick labs/ facilities
Full details

Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination

Authors (25)
The Lancet
Published
Crick labs/ facilities
Full details

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans

Authors (47)
Science
Published
Crick labs/ facilities
Full details

Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers

Authors (341)
The Lancet
Published
Crick labs/ facilities
Full details